LC Exam 2 Breast Flashcards

1
Q

Risk factor for breast cancer with relation to pregnancy

A

Age at/after pregnancy

Increased age increases risk and delay until protection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

AAP recommendation for breast feeding
Advantages for baby
Advantages for mom

A

6 months
Reduces many disease risks in preterm infants (meningitis, nec enterocolitis, ears, UTIs etc)
Decreased risk of SIDS, diabetes, cancer, etc etc
Mom: decreased menstrual bleeding, increased child spacing, faster return to pre-preg weight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Anatomy of human breast

A

7 lobes

Secretory epithelial cells and myoepithelial cells (lobuloalveolar unit)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Lactating vs. non-lactating breast composition

A

Lactating: Glandular = 62%, intraglandular fat = 7%
Non-lac: Glandular = 20%, intraglandular fat = 49%
Subq and retro fat remain the same

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Breast development cycles

A
Embryogenesis (establish gland)
Puberty
Mature
Pregnancy
Lactation cycle (and menstrual cycle, like mini lactation cycle)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Embryogenesis of breast

A

Ectoderm invades mesenchyme
Mesenchyme differentiates into fat pad (mammary mesenchyme)
Driven by PTHrP
No PTHrP = Blomstrands chrondroplasia (amastia)
Neonatal breast tissue can secret under right maternal hormonal conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Menstrual cycle changes in breast tissue

A

More ducts with LH/E2 spike
More alveoli with prog (luteal phase)
In preg= alveoli differentiation/side branches are a result of progesterone and PRL secretion by placenta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pubertal breast changes

A

Glandular expansion driven by E2 and progesterone
E2 + GH induce IGF-1 secretion from stromal cells (TEB)
Progesterone during menstrual phase = side branches (TDLU) development -> regress at end of luteal unless pregnancy
TEB = terminal end bud
TDLU = terminal ductual lobular unit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Initial pregnancy breast changes

Lactogenesis I

A

Differentiation:
Increased lobulation
Alveolar cell differentiation
Inhibition of milk secretion (by high levels of progesterone)
Hormones: E2, prog, placental lactogen, PRL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Later pregnancy breast changes

Lasctogenesis II

A

Removal of placenta (progesterone) -> milk secretion
Elevated PRL levels from pituitary required to maintain
Retained placenta can inhibit breastfeeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Lactation post-delivery

A

PRL: maintains lactation and inhibits reproductive fxn
OXY: assists milk letdown

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Breastfeeding nutrition for infants

A

Maternal igs (mostly IgA)
Macrophages
Lymphocytes
Exclusively breastfed infants require vitamin D supplementation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Breastfeeding decreases risk of which disease for baby

A
Infections
Asthma
Allergies
DM
Obesity
Bonding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Breastfeeding decreases risk of which cancers for mom

A
OXY release -> decrease pp hemorrhage
More rapid return to prepartum weight
Breast cancer
Ovarian cancer
Bonding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Milk secretion factors vs. milk letdown factors

A

Secretion: PRL and milk removal
Letdown/ejection: Oxytocin and suckling
Suckling also inhibits dopamine from hypothalamus ->
Stimulates PRL release from anterior pit
Operant conditioning can also stimulate hypothalamus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Other factors affecting breastfeeding

A
Stress
Delayed initiation
Pituitary damage
Excessive weight ->
(inhibits initiation, duration, PRL response to suckling, reduced ability to modify metabolic demand)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Human vs. bovine milk

A

Human contains necessary oligosacchrides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Milk composition/volume with days postpartum

A
Composition changes with volume
Volume increases
Tight junctions close
IgA secretion rises then falls
Leukocytes falls
Increased nutrition and decreased immunity with days postpartum
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Role of milk removal in breastfeeing

A

Removal of milk is required to maintain tight junction closure in glandular system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Prior pregnancy affect on breastfeeding

A

Prior pregnancy primes glandular system for new round of breastfeeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Colostrum

A

Milk produced following birth
Yellow
High in IgA, lactoferrin (anti-infection)
High protein, low fat/lactose
Facilitates lactobacillus and passage of meconium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Transitional milk (2-14 days)

A

Igs and proteins decrease
Lactose, fat, and calories increase
Vitamin changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Mature milk

A

Water: main component
Lipids: 50% calories, content varies with time
Proteins: Casein and whey, lactoferrin (inhibits Fe dependent bacterial growth in GI tract)
IgA/microbal factors
CHO, iron, zinc, vitamins (need vit D supplementation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Variation during feeding

A

Foremilk: more liquidy, less dense
Hindmilk: more dense

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Malnourished mothers

A

Same proportion of macromolecules

Less amount

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Maternal contraindications to breastfeeding

A

Medications
Untreated EtOH or drug abuse
Infections (TB, HIV in developed countries)
Undeveloped countries: HIV okay unless have access to clean water and formula

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Takeaways from 10 step Baby Friendly Hospital Inititave

A
Written breastfeeding policy
Help initiate within 30 min of birth
No other food or drink unless medically indicated
Mom and baby stay together
Feed on demand, no pacifiers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

The Golden Hour (not sunrise/sunset, but the first hour after birth)

A

Feed within 30 min (baby gets sleepy)
Skin to skin (thermoregulation)
Breastfeeding crawl (not done but she said it was super “cool”, which is odd)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Feeding in the first 1-3 days

A

Colostrum is low volume, high fat/protein/Ig
Glycogen stores provide 12 hours
Lipogenesis keeps baby going, low volume is enough
Milk comes in day 3-4 (later in 1st birth and C-section)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Infant weight

A

Expected to lose 5-7% of birth weight (lipogenesis while milk comes in)
Losses stop typically around day 5
Regain of BW by day 7-14

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Common problems

A

Pain/damage leads to engorgement, harder to pass milk, more often feedings, more pain/damage (cycle)
Primary lactation failure (rare)
Insufficient milk syndrome (inadequate removal leading to inadequate production)

32
Q

Alternatives to breastfeeding

A

Formula
1st line: Cow base (modified for casein:whey ratio)
2nd: Soy
Formula generally has more total protein (9 vs 15g)

33
Q

Risks with formula

A

Increased risk of atopy (developing allergies)
Increased risk of T1DM via autoimmune against bovine?
Increased risk of obesity (easier to get milk out, try and finish bottle - inhibits self regulation, leading to early/rapid weight gain)

34
Q

Infant growth

A

Same for first 3 months
After: formula fed gain more weight
Biggest difference: around 6 months
Known for a while, now a concern for later obesity
Use WHO growth charts 0-2 yrs of age (not CDC)

35
Q

Galactorrhea causes

A
  1. Excessive nipple stimulation
  2. Prolactinoma
  3. Drugs
36
Q

Inflammatory breast pathologies

A
Acute mastitis
Chronic mastitis
Periductal mastitis
Mammary duct ectasia
Fat necrosis
37
Q

Ductal system basics:
Epithelium
Stroma
Lobules male vs. female

A

Fxnal unit = terminal duct lobular unit
Two layered epithelium: epi cells and myoepi cells
>2 layers and loss of myoepi = pathologic
Interlobular stroma is regular fibrous tissue
Intralobular stroma is specialized and responsive to hormones
No lobules in male breast (or female prior to menarche)

38
Q

Changes in breast composition with:
Lactation
Age

A

Lactation: increased lobular size and space, less stroma
Age: decreased interlobular stroma (more fat, less fibrous)

39
Q

Potentially developmental abnormalities of the breast

A

Accessory breast tissue or increased nipples (anywhere along milk line - inguinal to axilla, most commonly axilla)
Congenital inverted/retracted nipples (careful of cancer)
Juvenille hypertrophy

40
Q

Gynecomastia

A

Increased ducts and stroma (mostly stromal)
Unilateral or bilateral
Increase in E2
Many causes

41
Q

Acute mastitis

A

Young female, just started lactating
Irritation, infection (staph/strep)
Tx: continued drainage and abx (diclox)
Close follow up warranted (inflammatory carcinoma)

42
Q

Chronic mastitis

A

Perimenopausal most common
Duct ectasia
Obstruction due to thickened secretions
Fibrosis and irregular mass formation

43
Q

Recurrent subareolar abcess periductal mastitis

A

Squamous metaplasia leading to closure and abscess

Common in smokers

44
Q

Fat necrosis

A

Related to trauma
Mass with calcifications (saponification)
Early: necrotic fat, PMN’s
Late: macs, giant cells, fibrosis, Ca2+cation

45
Q

Benign neoplasm of breast

A

Fibroadenoma
Lactating adenoma
Phyllodes tumor
Papilloma

46
Q

Fibroadenoma

A

Premenopausal women
Origin: TDLU, fibrous tissue and ductal tissue
Well-circumscribed, mobile
E2 sensitive
No increased risk of carcinoma (as long as no epithelial hyperplasia)

47
Q

Lactating adenoma

A

Presents during preg/lactation
Circumscribed, soft mass
Proliferation of small tubular structures with lactational changes

48
Q

Phyllodes tumor

A

Fibroadeonma like- increased fibrous component pushing out to from leaves in cystic spaces
Can be benign, low grade (recur), high grade (mets)
Epi is benign, stroma can be malignant

49
Q

Papilloma

A

Proliferation of epithelium (finger like projections with 2 cell layer)
Present as small mass with bloody discharge
Must r/o carcinoma (lack of myo or more than 2 layers)

50
Q

Breast cancer etiologies

A
  1. Sporadic (70-80%)
  2. Hereditary (10-15%) - BRCA positive
  3. Familial (20-25%) - FHx but BRCA negative
    (CHEK2, other tumor suppressor genes)
51
Q

Syndromes associated with hereditary breast cancer and mutations

A

Li Fraumeni: p53
Cowden: PTEN
Peutz-Jeghers: STK11/LKB1

52
Q

3 causes for increased incidence of breast cancer in western countries

A
  1. Delayed first pregnancy
  2. Fewer pregnancies
  3. Adoption of western diet/lifestyle
53
Q

Atypical breast hyperplasia

A

Can be ductal or lobular
On spectrum in between in-situ and hyperplasia
Increased risk of invasive carcinoma

54
Q
Ductal carcinoma in situ:
Characteristics
S/Sx
Tx
Low vs high grade
A

Proliferation of cells in ducts with no BM invasion
Calcification on mammography, no mass on exam
E-Cadherin POSITIVE
Risk of invasive
Excision usually cures
Low grade: often hormone receptor mutation (ER, PR)
High grade: often HER2/NEU overexpression

55
Q

DCIS: subtypes and grade

A

In general, increasing cells in the ducts
Cribiform variant
Papillary variant
Solid variant
Micropapillary (no fibrovascular core, hobnail cells)
Comedo: high grade

56
Q

Paget disease of the breast/nipple

A

Ulcerated nipple (often confused with eczema)
Associated with underlying carcinoma
Acanthosis (often confused with melanoma)

57
Q

Lobular carcinoma in situ

A
Usually only solid
No mass or calcifications, often incidental finding
Often multifocal and bilateral
E-cadherin NEGATIVE
Increased bilateral invasive risk
58
Q

Invasive carcinoma of the breast

A

Mass forming
Locally advanced disease: fixation and dimpling
Most commonly upper, outer quadrand
Mets first to axillary LN

59
Q

Inflammatory carcinoma (invasive ductual)

A

Inflammed swollen breast
Lymph drainage block, diffuse dermal LN involvement
Looks like acute mastitis (fail abx)
Poor prognosis

60
Q

Invasive ductal carcinoma

A

Well to poorly differentiated
Most common type of invasive carcinoma
Mets to lungs and pleura

61
Q

Invasive lobular carcinoma

A
Loss of E-cadherin
Express hormone receptors
No HER2/Nau overexpression
Single-file pattern
Mets to CSF, GI, ovaries
62
Q

Tubular carcinoma

A

Really good prognosis, so need to be sure

Well differentiated tubules that lack myoepithelial cells

63
Q

Types of invasive ductal carcinoma

A

Tubular
Mucinous
Medullary
Inflammatory

64
Q

Mucinous carcinoma

A
carcinoma with tumor cells floating in mucus
Well circumscribed
Older age group
Good prognosis
Hormone receptors and BRCA1 positive
No HER/Neu over-expression
65
Q

Medullary carcinoma

A

Large, high grade cells in sheets with lymphs and plasma cells
Triple negative, BRCA1
Good prognosis

66
Q

Metaplastic carcinoma

A

Non-glandular growth
Usually ER/PR negative
Fast growing
No differentiation, ugly, high mitotic activity, squamoid

67
Q

Stromal breast tumors

A

Angiosarcoma

68
Q

Angiosarcoma

A

Spindle cells

Extravasation of blood vessels

69
Q

Mixed stromal/epithelial

A

Phyllodes tumor

70
Q

Phyllodes tumor

A

Fibroadenoma like, but can be malignant

Much higher fibrous/stromal component

71
Q

Lymphoid breast tumors

A

Mantle cell lymphoma
CLL
Diffuse Large B cell

72
Q

Pathogenesis: ER positive

A

ER positive, HER2 negative (50-65%)
Gain of 1q, loss of 16q, PIK3 activating
Associated with lower grade, better prognosis

73
Q

Molecular pathways of pathogenesis

A
ER positive, HER2 negative (50-65%)
HER2 positive (20%)
Triple negative (15%) - BRCA1 associated, worst prog
74
Q

Pathogenesis: HER2 positive

A

Associated with Li Fraumeni
Amplification of HER2 on 17q
Associated with higher grade

75
Q

Biomarkers and response to therapy

A

ER/PR mutation = tamoxifen
HER2 = Herceptin
Triple negative = poor prog

76
Q

Male breast cancer

A

Subareolar mass, involve chest wall and skin
Assoc with BRCA2 and Klinefelter
Stage for stage/grade for grade equal to females
Often present at later stage